|
|
|
|
| LEADER |
01703nam a2200337 u 4500 |
| 001 |
EB002001945 |
| 003 |
EBX01000000000000001164846 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
210907 r ||| eng |
| 100 |
1 |
|
|a Banerjee, Srabani
|
| 245 |
0 |
0 |
|a Probiotics for antibiotic-associated diarrhea and clostridium difficile infection
|h Elektronische Ressource
|b a review of guidelines
|c Srabani Banerjee, Lorna Adcock
|
| 250 |
|
|
|a Version 1.0
|
| 260 |
|
|
|a Ottawa
|b CADTH
|c 2018, September 6, 2018
|
| 300 |
|
|
|a 1 PDF file (16 pages)
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Diarrhea / therapy
|
| 653 |
|
|
|a Probiotics / standards
|
| 653 |
|
|
|a Anti-Bacterial Agents / adverse effects
|
| 653 |
|
|
|a Clostridium Infections / therapy
|
| 653 |
|
|
|a Probiotics / therapeutic use
|
| 653 |
|
|
|a Diarrhea / prevention & control
|
| 653 |
|
|
|a Clostridium Infections / prevention & control
|
| 700 |
1 |
|
|a Adcock, Lorna
|e [author]
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK537875
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a The purpose of this report is to review the evidence-based guidelines regarding the use of probiotics for the prevention, management, and treatment of antibiotic associated diarrhea and Clostridium difficile (C. difficile) infection. A second CADTH report to be published subsequently will review the clinical effectiveness of probiotics
|